Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about European projects that are funded by European programmes including FP7, H2020, IMI, JNPD, AAL and EU Health. For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Analysis of eye vergence responses for the early detection and monitoring of cognitive and mental disorders

MindTrack

Cognitive and mental disorders such as Dementia, Alzheimer´s, depression and Parkinson's disease, some of them closely related to ageing populations, have high social and economic burden. Nowadays, neurologists, psychiatrists, psychologists, gerontologists and general practitioners rely on subjective, time-consuming semi-structured interviews and...
Funding Programme
Start Date
End Date
Total Funding
€ 71 429
European Countries Involved

ANDALUSIAN RESEARCHERS´NIGHT 2012

ANDARES

As part of the Innovation policy of Andalusian Region, Fundación Descubre (www.fundaciondescubre.es) with the University of Almeria, University of Cordoba, University of Granada, University of Huelva, University of Malaga, Pablo de Olavide University, University of Seville, Jaen University and National Research Council (CSIC), the Association of...

Funding Programme
Start Date
End Date
Total Funding
€ 165 217
European Countries Involved

BEHAVIOUR PATTERN BASED ASSISTANT FOR THE EARLY DETECTION AND MANAGEMENT OF NEURODEGENERATIVE DISEASES

BEDMOND

The BEDMOND project aims at developing an ICT-based system for an early detection of  Alzheimer’s disease and other neurodegenerative diseases, based on a behavioural change to approach and focused in elderly people while living at home in an Ambient Assisted Living  environment. With such an early detection health professionals can later on apply...

Funding Programme
Start Date
End Date
Total Funding
€ 2 379 179
European Countries Involved

Bioactive compounds from blackcurrant processing waste for brain health

BRAINHEALTHFOOD

Alzheimer's disease (AD) is the most common age-related neurodegerative disorder, and one of the most devastating diagnoses that patients and their families can receive. Currently ~10 % of over 65 year old have AD, and the direct and indirect cost of its care is estimated to be >100 billion $ in the US alone and in the UK ~ €22M, and therefore...

Funding Programme
Start Date
End Date
Total Funding
€ 1 139 467
European Countries Involved

Biomarker based diagnosis of rapid progressive dementias – optimisation of diagnostic protocols.

DEMTEST

DEMTEST has established a large European and global collaboration between national surveillance units and dementia research centres, facilitating cooperation between neurologists, neuropathologists and neuroscientists. We work on standardisation of tests that are currently available and harmonise their use between centers worldwide. We define...
Funding Programme
Start Date
End Date
Total Funding
€ 2 200 000

Biomarkers for Alzheimer’s disease and Parkinson’s disease.

BIOMARKAPD

Neurodegenerative disorders, represented mostly by Alzheimer's disease (AD) and Parkinson's disease (PD), are characterised by progressive neuronal impairment and death. In spite of the brain's known capacity for regeneration, lost neurons generally cannot be replaced. Therefore, drugs aimed at inhibiting neurodegenerative processes are likely to...

Funding Programme
Start Date
End Date
Total Funding
€ 449 066

Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease

BBDiag

Alzheimer’s disease (AD) affects more than 7 million people in Europe and this figure is expected to double every 20 years. Despite intensive efforts, no disease-modifying treatments or preventive strategies are available. The lack of specific, sensitive and minimally invasive diagnostics to identify people with early-stage AD to be included in...

Funding Programme
Start Date
End Date
Total Funding
€ 3 465 708
European Countries Involved

blood Proteins for early Discrimination of dEmentias

bPRIDE

Dementia is a group of disorders characterized by severe memory loss ultimately impairing daily life activities. Major forms are Alzheimer’s disease, Lewy body dementia, and frontotemporal dementia. Each dementia type is caused by different biological factors and therefore requires a specific treatment targeting these factors. To develop effective...
Funding Programme
Start Date
End Date
Total Funding
€ 1 800 000
European Countries Involved

Calcium-Sensing Receptor (CaSR): Therapeutics for Non-Communicable Diseases

CaSR Biomedicine

The calcium sensing receptor (CaSR) is a class C Gprotein-coupled receptor that plays a pivotal role in systemic calcium metabolism by regulating parathyroid hormone secretion and urinary Ca excretion. Abnormal CaSR function is implicated in calciotropic disorders, and in non-calciotropic disorders such as Alzheimer’s disease (AD), cardiovascular...
Funding Programme
Start Date
End Date
Total Funding
€ 3 657 195

Clot formation as a potential diagnostic tool and therapeutic target for Alzheimer's disease

ADVASCULATURE

Alzheimer’s disease (AD) is the leading cause of dementia in the elderly. Accumulating evidence links AD with vascular risk factors. These correlations, together with profound alterations of cerebrovascular structure and function present in AD, suggest a “vascular hypothesis”, where vascular pathology eventually leads to neurodegeneration and...
Funding Programme
Start Date
End Date
Total Funding
€ 230 037
European Countries Involved

CLOUD-BASED MULTIMODAL NEUROIMAGING PLATFORM

Neurocloud

One of the main socioeconomics challenges to be faced in the next decades will be the prevalence of neurodegenerative diseases (such as Alzheimer’s and Parkinson’s) due to population ageing. Today, diagnosis, treatment and monitoring of such illness is complex, a laborious process completed by a limited set of Neurologist experts who need to...

Funding Programme
Start Date
End Date
Total Funding
€ 71 429
European Countries Involved

Cognition, ageing, and bilingualism: Investigating age-related changes in bilingual language switching and use.

CAB

Older adults show difficulties with bilingual language processing and switching compared to younger adults. For example, they need more time to switch between languages and show more cross-language intrusions. Language problems have not only been found for healthy older adults, but also in patients with dementia and Parkinson’s disease. Language...
Funding Programme
Start Date
End Date
Total Funding
€ 158 122
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).